National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non–Small Cell Lung Cancer

Abstract

Background: There exists wide practice variability in palliative treatment schedules for bone metastases. In an effort to reduce variation and promote high-quality, cost-conscious care, the National Quality Forum (NQF) endorsed measure 1822 in 2012. This measure recommends the use of 30 Gy in 10 fractions, 24 Gy in 6 fractions, 20 Gy in 5 fractions, or 8 Gy in a single fraction for palliative radiation for bone metastases. We report on longitudinal compliance with this measure. Methods: Using the National Cancer Database, patients with metastatic thoracic non–small cell lung cancer diagnosed between 2004 and 2016 who received radiation therapy for bony sites of metastatic disease were identified. Treatment courses fitting 1 of the 4 recommended schedules under NQF 1822 were coded as compliant. Rates of compliance by patient, tumor, and treatment characteristics were analyzed. Results: A total of 42,685 patients met the criteria for inclusion. Among all patients, 60.2% of treatment courses were compliant according to NQF 1822. Compliance increased over time and was highest for treatments to the extremity (69.8%), lowest for treatments to the skull or head (48.8%), and higher for academic practice (67.1%) compared with community (56.0%) or integrated network facilities (61.2%). On multivariable analysis, predictors of NQF 1822 compliance included year of diagnosis after 2011, treatment to an extremity, or treatment at an academic facility. Of noncompliant treatment courses, extended fractionation (≥11 fractions) occurred in 62.6% and was more common before 2012, in community practice, and for treatments of the skull or head. Conclusions: Among patients treated for metastatic non–small cell lung cancer, compliance with NQF 1822 increased over time. Although extended fractionation constituted a majority of noncompliant treatment courses, a substantial proportion also involved shorter courses.

Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer

“…The finding of an association between academic cancer centers and use of shorter courses of RT is consistent with results reported in the literature . The reasons for this observation are likely multifactorial and vary by center.…”

“…The finding of an association between academic cancer centers and use of shorter courses of RT is consistent with results reported in the literature. 11,12 The reasons for this observation are likely multifactorial and vary by center. These reasons include greater access to larger teams and peer training, onsite didactics, journal access, acquisition of capital, and potentially different financial incentives for clinicians.…”

Quality of palliative radiotherapy assessed using quality indicators: a multicenter survey

“…Two previous studies that investigated the appropriate selection of dose schedules in radiotherapy for BoM [ 26 , 27 ] reported comparable and lower compliance rates than ours (i.e. the pooled compliance rate of 99% for the use of fractions ≤10 for painful BoM [BoM-1]).…”

Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide

“…Patients with lung cancer commonly present with bone metastases. 58 Multiple lytic bone lesions assuredly suggest metastatic disease, so histologic or cytologic evidence of bone metastases is not needed in this case. The patient had an accessible lesion so that a bronchoscopy with EBUS-TBNA provided a cytologic diagnosis.…”

“…Patients with lung cancer commonly present with bone metastases 58 . Multiple lytic bone lesions assuredly suggest metastatic disease, so histologic or cytologic evidence of bone metastases is not needed in this case.…”